🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Substudy 03A is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 1008)
Start Date
2020-12-16
Trial ID
NCT04626479
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2026-09-01
Trial ID
NCT07793695
This study will compare the efficacy and safety of belzutifan + lenvatinib ...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0077)
Start Date
2021-02-25
Trial ID
NCT04586231
Treatments Being Tested
Substudy 03B is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 3008)
Start Date
2020-12-17
Trial ID
NCT04626518
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of pembrolizu...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham ( Site 0010)
Start Date
2021-04-14
Trial ID
NCT04736706
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313
Start Date
2023-09-21
Trial ID
NCT05822752
Treatments Being Tested
This study will evaluate the effect of investigational drugs, pembrolizumab...
Status
Recruiting
Location
Abramson Cancer Center at University of Pennsylvania
Start Date
2023-05-03
Trial ID
NCT05733715
Treatments Being Tested
This is a single-arm, multicenter, Phase 2 study of lenvatinib in combinati...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-02-20
Trial ID
NCT02915783
Treatments Being Tested
In China, the majority of hepatocellular carcinoma (HCC) cases stem from ch...
Status
Not Yet Recruiting
Location
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology
Start Date
2025-12-31
Trial ID
NCT07350070
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573